Dahan Biomedical Announces Board Resolution on 2026 First Quarter Earnings Distribution and Cash Dividend

1. Date of board resolution: 2026/05/07 2. Fiscal year (quarter) to which the dividend belongs: 2026 Q1 3. Dividend period: 2026/01/01 to 2026/03/31 4. Shareholder distribution content: (1) Cash dividend from earnings distribution (NT$/share): 0.11594660 (2) Cash from legal reserve distribution (NT$/share): 0 (3) Cash from capital reserve distribution (NT$/share): 0.74071864 (4) Total cash dividend distributed to shareholders (NT$): 693,919,552 (5) Stock dividend from earnings surplus (NT$/share): 0 (6) Stock dividend from legal reserve surplus (NT$/share): 0 (7) Stock dividend from capital reserve surplus (NT$/share): 0 (8) Total shares distributed to shareholders (shares): 0 5. Other matters to be specified: None 6. Par value per common share: NT$1.0000